Boston Scientific to Participate in Wells Fargo's 2024 Healthcare Conference

Rhea-AI Summary

Boston Scientific (NYSE: BSX) has announced its participation in Wells Fargo's 2024 Healthcare Conference on September 4, 2024. The company's chairman and CEO, Mike Mahoney, along with Dr. Brad Sutton, chief medical officer of Atrial Fibrillation Solutions, will engage in a 35-minute Q&A session with the host analyst, starting at approximately 8:00 a.m. ET.

Investors and interested parties can access a live webcast of the session through the Boston Scientific investor relations website. A replay of the event will be made available about an hour after its conclusion, providing an opportunity for those unable to attend the live session to catch up on the discussion.

News Market Reaction – BSX

-0.03%

-0.03% Session move

In the trading session that priced this news, BSX declined 0.03%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Wells Fargo's 2024 Healthcare Conference on Wednesday, September 4, 2024.

Mike Mahoney, chairman and chief executive officer, and Dr. Brad Sutton, chief medical officer, Atrial Fibrillation Solutions, will participate in a 35-minute question-and-answer session with the host analyst at approximately 8:00 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-wells-fargos-2024-healthcare-conference-302219961.html

SOURCE Boston Scientific Corporation

FAQ

When is Boston Scientific (BSX) participating in Wells Fargo's 2024 Healthcare Conference?

Boston Scientific (BSX) is participating in Wells Fargo's 2024 Healthcare Conference on Wednesday, September 4, 2024.

Who will represent Boston Scientific (BSX) at the Wells Fargo Healthcare Conference?

Mike Mahoney, chairman and CEO, and Dr. Brad Sutton, chief medical officer of Atrial Fibrillation Solutions, will represent Boston Scientific (BSX) at the conference.

What format will Boston Scientific's (BSX) presentation take at the Wells Fargo conference?

Boston Scientific's (BSX) presentation will be a 35-minute question-and-answer session with the host analyst.

At what time does Boston Scientific's (BSX) Q&A session start at the Wells Fargo conference?

Boston Scientific's (BSX) Q&A session is scheduled to start at approximately 8:00 a.m. ET on September 4, 2024.

How can investors access Boston Scientific's (BSX) presentation at the Wells Fargo conference?

Investors can access a live webcast of Boston Scientific's (BSX) presentation through the company's investor relations website at investors.bostonscientific.com.